HOME >> MEDICINE >> NEWS
Patients are sought for a clinical study to determine

September 17, 1999--Hormone replacement therapy has been shown to protect women against heart disease, stroke and Alzheimer's disease. Now, researchers at Rush-Presbyterian-St. Luke's Medical Center have begun a clinical trial to determine if estrogen also improves the effectiveness of drugs used to treat Parkinson's patients.

Currently the most common treatment for Parkinson's patients is a daily regimen of the drug Levodopa. While many patients benefit from consistent use of Levodopa, the effects of the drug wear off after two or three hours, creating a "roller coaster" effect. Recently, a drug called Mirapex has proven effective at leveling these ups and downs, and preliminary information suggests hormone replacement therapy can enhance these effects.

Dr. Aikaterini Kompoliti, a neurologist at Rush-Presbyterian-St. Luke's Medical Center, is heading a team of researchers investigating whether estrogen can extend this period of effectiveness and further smooth out the ups and downs caused by Levodopa.

Rush is one of two medical centers taking part in this double-blind, placebo trial that will study 36 patients. The other center is the Mayo Clinic in Scottsdale, Ariz.

Parkinson's occurs when the brain cannot produce enough dopamine, causing patients to lose the ability to control their own movements. Levodopa and Mirapex are dopamine agonists that work by fooling the brain into thinking that dopamine exists. When effective, these medications allow patients to regain some control over their motor functions.

"Our hypothesis is that estrogen will work with the Mirapex and Levodopa to increase and enhance the effectiveness of both drugs," said Kompoliti. Each medical center in the trial will treat 18 patients who are already on Levodopa: six will be men on Levodopa; six will be post-menopausal women on Levodopa, but not estrogen; and six will be post-menopausal w
'"/>

Contact: Chris Martin
cmartin@rsh.net
312-942-7820
Rush University Medical Center
17-Sep-1998


Page: 1 2

Related medicine news :

1. Patients newly diagnosed with HIV are more likely to enter outpatient care with case management
2. Patients with cancer have highly increased risk for blood clots
3. Patients with previous heart attacks may not benefit from pacemaker implant
4. Patients with cancer detected on screening mammography undergo less toxic treatment
5. Patients with moderate or severe hand dermatitis responsive to drug therapy
6. Patients with abdominal trauma at risk for intra-abdominal infections following surgery
7. Patients who are intubated prior to hospital arrival fare worse find Pitt researchers
8. Patients undergoing weight loss surgery have high rates of H pylori bacteria
9. Patients with chronic sinus do not necessarily develop antibiotic resistance
10. Plastic surgeons honor Patients of Courage overcoming difficult obstacles, inspiring others
11. Patients with severe depression improve using guidelines developed by UT Southwestern researchers

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Patients are sought for clinical study determine

(Date:5/21/2013)... Dallas-based TopMD™ Skin Care today announced ... the efficacy of their flagship product, CLn® BodyWash ... results appear in the May/June 2013 issue of ... Sodium Hypochlorite Cleanser Shows Clinical Response and Excellent Acceptability ... seen after consistent use of the product by 18 ...
(Date:5/21/2013)... Rochester, MN (PRWEB) May 21, 2013 ... and the world’s leading work-life services provider, and ... offer enhanced wellness services. In an initiative set ... adopt Mayo Clinic’s coaching model into its existing ... to Mayo Clinic’s current commercial client base in ...
(Date:5/21/2013)... Reporter , , MONDAY, May 20 (HealthDay News) -- ... with chronic obstructive pulmonary disease (COPD) may raise ... a new large Canadian study reveals. The ... are prescribed long-acting bronchodilators -- either anticholinergics (such ... medications are commonly used to relieve the shortness ...
(Date:5/21/2013)... of physical activity appears to be an independent ... obstructive pulmonary disease (COPD) will end up being ... researchers in Connecticut. The study also corroborates an ... with an increased incidence of hospitalizations among patients ... will be presented at the ATS 2013 International ...
(Date:5/21/2013)... AZ (PRWEB) May 21, 2013 This ... dedicated to cultivating conation. Organized by Kolbe Corp, the ... of instinctive human strengths, and inspire attendees to take ... event, taking place October 10th and 11th, will feature ... Dr. Diane DeBacker, Commissioner of Education for Kansas where ...
Breaking Medicine News(10 mins):Health News:Peer-Reviewed Article Shows CLn® BodyWash an Effective Solution for Children with Eczema 2Health News:Peer-Reviewed Article Shows CLn® BodyWash an Effective Solution for Children with Eczema 3Health News:Workplace Options and Mayo Clinic Announce Strategic Relationship 2Health News:Workplace Options and Mayo Clinic Announce Strategic Relationship 3Health News:Certain COPD Meds Might Raise Heart Risks, Study Says 2Health News:Certain COPD Meds Might Raise Heart Risks, Study Says 3Health News:Exercise levels may predict hospitalizations in COPD population 2Health News:A New Destination for Thought Leaders - Kolbe Corp's Conation Nation Symposium 2
(Date:5/21/2013)... MOUNTAIN VIEW, Calif. , May 21, 2013 /PRNewswire/ ... Brazil , Russia , ... (BRIC) are realizing there are no shortcuts.  This ... especially in the United States.  Companies must change the ... establishing value, customizing to local needs, and building regional ...
(Date:5/21/2013)... -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: ... cell based therapies for various personal applications, announced that ... CEO, will be presenting at the Marcum MicroCap Conference.   ... Thursday, May 30, 2013 at the Grand Hyatt Hotel, ... City.  Mr. Weinreb,s presentation will take place at 2:30 ...
(Date:5/21/2013)... 21, 2013  AcelRx Pharmaceuticals, Inc. (Nasdaq: ... company focused on the development and commercialization ... acute and breakthrough pain, today announced top-line ... 3 study of its investigational sublingual Sufentanil ... the primary efficacy endpoint was achieved.  The ...
Breaking Medicine Technology:Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 2Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 3Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 4BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 3Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 2Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 3Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 4Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 5Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 6Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 7Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 8Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 9Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 10
Cached News: